Parexel opened a new early phase unit in Port Elizabeth, South Africa, giving the contract research organization (CRO) its third early-phase facility in that country.
The new unit adds 40 beds to Parexel’s global early phase capacity of 580 beds. The CRO’s other South African early phase units are in Bloemfontein and George, and global facilities are located in the U.S., UK and Germany.
The main focus of the new facility will be conducting early phase studies—from first-in-man to proof of concept—in patients.
"The opening of our early phase unit in Port Elizabeth represents Parexel’s further commitment to offering rapid recruitment solutions to our clients,” said Michelle Middle, corporate vice president and worldwide head of early phase, in a statement. “Port Elizabeth joins our other early phase units, which are integrated and harmonized to handle complex global studies involving healthy volunteers and patient populations."